AI assistant
Sending…
Perspective Therapeutics, Inc. — Director's Dealing 2018
Mar 2, 2018
33510_dirs_2018-03-02_4641a097-3681-4198-bd1a-54d953e38a4c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2018-03-01
Reporting Person: LAVOY THOMAS C (Director, CEO and Chairman of the Board)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-03-01 | Common Stock | P | 4186 | $0.43 | Acquired | 270519 | Direct |
| 2018-03-01 | Common Stock | P | 45814 | $0.44 | Acquired | 316333 | Direct |
More from Perspective Therapeutics, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
May 12
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 27
Regulatory Filings
2026
Apr 20
Proxy Solicitation & Information Statement
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16